The effect of different indomethacin formulations in young and elderly patients: a comparative controlled clinical trial.
Kaarela K, Lehtinen K, Skinhøj A, +1 more·Current medical research and opinion
In a double-blind, crossover trial a controlled-release multiple-units indomethacin formulation (50 mg twice daily) was compared with conventional capsules (25 mg twice daily with 50 mg in the evening) in 12 young and 18 elderly in-patients with rheumatoid arthritis. Earlier findings that younger patients preferred a s…